Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Operating Expenses (2020 - 2025)

Celularity (CELU) has disclosed Operating Expenses for 6 consecutive years, with $18.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses fell 12.67% to $18.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $89.1 million, a 39.31% increase, with the full-year FY2024 number at $92.6 million, down 56.95% from a year prior.
  • Operating Expenses was $18.2 million for Q3 2025 at Celularity, down from $21.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $107.0 million in Q3 2021 to a low of -$13.4 million in Q4 2022.
  • A 5-year average of $34.2 million and a median of $22.1 million in 2024 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: surged 30542.6% in 2021, then tumbled 167.43% in 2022.
  • Celularity's Operating Expenses stood at $19.8 million in 2021, then crashed by 167.43% to -$13.4 million in 2022, then soared by 90.99% to -$1.2 million in 2023, then skyrocketed by 2378.64% to $27.4 million in 2024, then plummeted by 33.66% to $18.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Operating Expenses are $18.2 million (Q3 2025), $21.6 million (Q2 2025), and $21.9 million (Q1 2025).